Skip to main content
. 2018 Dec 7;46(2):139–143. doi: 10.1111/1346-8138.14719

Figure 5.

Figure 5

Ratio of patients who showed progression of alopecia after showing peak efficacy. *P < 0.01 compared with basic and F type.